Drug Shortage Report for OXALIPLATIN INJECTION

Last updated on 2020-10-15 History
Report ID 126533
Drug Identification Number 02435071
Brand name OXALIPLATIN INJECTION
Common or Proper name OXALIPLATIN INJECTION 5MG/ML
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) OXALIPLATIN
Strength(s) 5MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 40ml
ATC code L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-10-14
Estimated end date 2020-12-14
Actual end date
Shortage status Actual shortage
Updated date 2020-10-15
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2020-10-15 French Compare
v2 2020-10-15 English Compare
v1 2020-10-15 English Compare